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LETTERS TO THE EDITOR
Comparing methods for
calculating GFR in children
and adults
To the Editor: In their recent study on glomerular fil-
tration rate (GFR), Pierrat et al [1] concluded that the
Cockcroft-Gault formula provided the “least misleading”
calculated GFR for adults and children over 12 years of
age. While this is important, the clinical population tar-
geted was not firmly established. The study suggested that
comorbidity was present in a majority of subjects, but
whether patients in a single group were similar in health
was unclear. Tables 2 and 3 did not indicate whether
subjects within groups shared similar comorbidities, and
the extent to which the children with two nontrans-
planted kidneys suffered from renal dysfunction or other
problems was unknown. The study also lacked an adult
nonsingle kidney nontransplanted group. Thus, the reli-
ability of the results, because of varied health status of
patients, is questionable, and the subjects are not neces-
sarily a significant improvement over previous subjects
studied.
Errors were also noted in the statistical analysis. In
place of standard error of the mean (SEM), the authors
should have used standard deviation (SD). SD measures
dispersion around a sample mean, whereas SEM mea-
sures how well the mean found approximates other means
found had the procedure been repeated. Also, post-hoc
tests are the appropriate procedure to perform after an
analysis of variance (ANOVA); the paired t tests in the
study violated the assumption of independence [2].
The study suggests the difficulty of accounting for all
factors in a GFR equation. Nevertheless, researchers
should continue studying the accuracy of these formu-
las and find a better means of approximating GFR to
improve patient care.
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Reply from the Authors
Drs. Narat and Karnath raise interesting comments
about patient populations and statistical methods used
to compare methods for calculating glomerular filtration
rate (GFR) in our recent article [1].
Indeed, comorbidity was present in almost all patients
because they were part of the reason why the renal lab
unit was consulted. We did not understand the ques-
tion “whether patients in a single group were in similar
health.” These hospitalized patients were not experimen-
tal lab subjects; therefore, similarity in health would have
been coincidental. Moreover, subjects served as their own
controls for an evaluation of the methods used to measure
the GFR.
We, too, regretted the missing of an adult nonsingle
kidney nontransplanted group; however, the lab is in a
children’s hospital.
Drs. Narat and Karnath are right when they point out
the absence of standard deviation in Tables 2 and 3. How-
ever, this parameter could be calculated from the others
in the tables.
The ANOVA study included post-hoc tests; we call
them “test t multiple prote´ge´” (protected multiple t test)
[2]. We chose a graphical representation (Figs. 1, 2, and
3) of what could be expected by a clinician using such or
such calculation instead of measuring inulin clearance;
therefore, P values were reported in figure legends as P
versus inulin clearance. With the significant P values used,
there was no difference between post-hoc t and paired
t tests.
We reported in a large population of children that
calculation of GFR with either method gives values very
different from true GFR (inulin clearance) under the
age of 12 years. In children aged 12 years and older, the
Cockcroft-Gault formula gave the closest value to true
GFR, with an approximation of ±40 mL/min/1.73m2.
The approximation was ±30 mL/min/1.73m2 in
adults.
We are grateful to Drs. Narat and Karnath for pointing
out the need for these precisions, and for emphasizing the
necessity of finding better means of approximating GFR
to improve patients’ care.
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MTHFR C677T polymorphism
and skin color: The white
man’s blackness
To the Editor: The C677T polymorphism of methyl-
enetetrahydrofolate reductase (MTHFR) gene is linked
to higher homocysteine levels and risk for myocardial in-
farction and stroke. MTHFR catalyzes the reaction, pro-
ducing methyltetrahydrofolate, the active form of folic
acid, in the remethylation of homocysteine to methio-
nine. Hyperhomocysteinemia is a known cardiovascular
risk factor, with effects on gene allelic expression in ure-
mic patients [1, 2].
The frequency of the C677T polymorphism is, in its ho-
mozygous TT form, about 20% and more in whites, and
1% or less in blacks from Africa or the United States
[3]. It has been proposed that a selective advantage in
possessing this variant lies in the capability to conserve
folates for DNA production during times of relative fo-
late deficiency. It is not clear why black people shouldn’t
possess this selective advantage.
A dark skin color has been recently envisioned as a
means through which man protects himself from folate
destruction because folates are highly susceptible to ul-
traviolet A (UVA) ray degradation. Skin color represents
a delicate balance between the need to produce enough
vitamin D and folate conservation, in particular when fo-
lates are scarce [4].
We put forward the hypothesis that in black people,
skin color allows for some vitamin D production, while it
protects from folate degradation, and no reason why the
MTHFR variant should have been favored. White people
instead have evolved in a population of individuals where
the MTHFR TT genotype is favored for folate conserva-
tion. Little sun exposure allows for limited folate degra-
dation, and in times of folate deficiency these individuals
would produce enough folates for DNA synthesis. There-
fore, the MTHFR thermolabile variant would represent
“the white man’s blackness.”
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Mitochondrial causes of renal
insufficiency and hearing loss
To the Editor: A recent paper in Kidney International
by Izzedine et al [1] provided an excellent review of ear
and kidney syndromes. We would like to call attention
to another syndrome that can be associated with hear-
ing loss and renal disease. Mutations in the mitochon-
drial gene MTTL1, which encodes tRNA Leu(URR), can
also cause renal dysfunction and hearing loss. In the most
severe form, mutations in this gene cause MELAS syn-
drome (Mitochondrial myopathy, Encephalopathy, Lac-
tic Acidosis, and Stroke), which is a multisystem disorder
that can present with cerebral vascular accidents, seizures,
hearing loss, cardiomyopathy, diabetes, and nephropathy.
Mutation analysis of MTTL1 in MELAS patients reveals
that 80% have the mutation A3243G, 7.5% have T3271C,
and 7.5% to 10% have A3253G [2].
We have evaluated three unrelated patients with the
MTTL1 A3243G mutation and features of MELAS syn-
drome: a 48-year-old man with a creatinine of 2.0 g/dL
who presented with cardiomyopathy, diabetes, and hear-
ing loss; a 22-year-old woman with an iothalamate clear-
ance of 67 mL/min who presented with cardiomyopathy,
history of a thalamic stroke, an elevated blood lactate, and
progressive hearing loss; and a 28-year-old woman with
an iothalamate clearance of 29 mL/min who presented
with hypertrophic cardiomyopathy, history of a stroke,
